I

IDBiologics, Inc.

10 employees

IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2017

Funding rounds raised

Total raised

$4.3M

from 4 investors over 4 rounds

I

IDBiologics, Inc. raised $500K on May 23, 2023

Investors: Vanderbilt University

I

IDBiologics, Inc. raised undisclosed on December 26, 2022

Investors: Acequia Capital

I

IDBiologics, Inc. raised undisclosed on September 15, 2021

Investors: LaunchTN

I

IDBiologics, Inc. raised $4.3M on May 20, 2020

Investors: FlyingPoint Industries

FAQ